Correlation of 18F-FDG PET/CT Findings With Histopathological Results in Differentiated Thyroid Cancer Patients Who Have Increased Thyroglobulin or Antithyroglobulin Antibody Levels and Negative 131I Whole-Body Scan Results-Reference-Cited by-同舟云学术

Correlation of 18F-FDG PET/CT Findings With Histopathological Results in Differentiated Thyroid Cancer Patients Who Have Increased Thyroglobulin or Antithyroglobulin Antibody Levels and Negative 131I Whole-Body Scan Results

Published:2013-05 Issue:5 Volume:38 Page:326-331
ISSN:0363-9762
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:

Author:

Ozkan Elgin,Aras Gulseren,Kucuk N. Ozlem

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference22 articles.

1. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.;Filesi;J Nucl Med,1998

2. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma.;Schlumberger;Eur J Endocrinol,1998

3. Papillary and follicular thyroid carcinoma.;Schlumberger;N Engl J Med,1998

4. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.;Haugen;J Clin Endocrinol Metab,1999

5. Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome.;Pacini;Acta Endocrinol (Copenh),1988

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incremental diagnostic value of SPECT/CT to post-radioiodine therapy planar whole-body scan in patients with papillary thyroid cancer;2023-11-09

2. The Diagnostic Value of ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin/Thyroglobulin Antibody Levels and Negative Iodine Scintigraphy: A Systematic Review and Meta-Analysis;Thyroid®;2023-10-01

3. Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus;European Journal of Endocrinology;2023-08

4. Follow-up after radioiodine remnant ablation in differentiated thyroid cancer: the view of nuclear medicine physician;Head and Neck Tumors (HNT);2023-06-01

5. Clinical characteristics and long‐term outcomes for parapharyngeal metastases of well‐differentiated thyroid cancer during ¹³¹I therapy and follow‐up;Clinical Endocrinology;2023-04-27